Large Study Shows Genetic Changes from Treatment May Be the Key to Personalized Care for Mesothelioma Patients

Researchers continue to focus projects on finding the key to offering physicians a reliable method for offering personalized treatment to their cancer patients.  While oncologists tend to rely on the combination chemotherapy treatment of pemetrexed and cisplatin for mesothelioma patients, researchers now believe that by “profiling genetic alterations in cancer with drug sensitivity” they may be able to identify an effective alternative for patients who do not respond to the treatment.

Read more at MesotheliomaHelp.net.